misonneh's adr [30 articles] Export

Recent papers added to misonneh's library classified by the tag adr. You can also see everyone's adr.

	Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events. [My Copy] The oncologist, Vol. 12, No. 7. (July 2007), pp. 864-872. by Jeffrey Weber posted to review response immunity adr by misonneh on 2009-11-27 11:01:45 as along with 1 person calvin
	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy [My Copy] Nature Genetics, Vol. 41, No. 12. (08 November 2009), pp. 1345-1349. by Colin J. D. Ross, Hagit Katzov-Eckert, Marie-Pierre Dube, et al.Beth Brooks, S. Rod Rassekh, Amina Barhdadi, Yassamin Feroz-Zada, Henk Visscher, Andrew M. K. Brown, Michael J. Rieder, Paul C. Rogers, Michael S. Phillips, Bruce C. Carleton, Michael R. Hayden posted to tpmt pharmacogenetics journal_club comt cisplatin chemotherapy association adr by misonneh on 2009-11-25 07:01:55 as
	Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy. [My Copy] Breast cancer research and treatment, Vol. 115, No. 3. (June 2009), pp. 643-650. by Adedayo A. Onitilo, Catherine A. McCarty, Russell A. Wilke, et al.Ingrid Glurich, Jessica M. Engel, David A. Flockhart, Anne Nguyen, Lang Li, Deming Mi, Todd C. Skaar, Yan Jin posted to tamoxifen pharmacogenetics hr genetics breast adr by misonneh on 2009-10-21 02:21:36 as
	Adverse event detection in drug development: recommendations and obligations beyond phase 3. [My Copy] American journal of public health, Vol. 98, No. 8. (August 2008), pp. 1366-1371. by Jesse A. Berlin, Susan C. Glasser, Susan S. Ellenberg posted to summary review guideline adr by misonneh on 2009-09-29 18:26:54 as
	High rates of adverse drug events in a highly computerized hospital. [My Copy] Archives of internal medicine, Vol. 165, No. 10. (23 May 2005), pp. 1111-1116. by Jonathan R. Nebeker, Jennifer M. Hoffman, Charlene R. Weir, Charles L. Bennett, John F. Hurdle posted to summary review adr by misonneh on 2009-09-29 18:25:12 as along with 2 people markvw13 dliebovi
	International Serious Adverse Events Consortium [My Copy] posted to pharmacogenetics consortium adr by misonneh on 2009-09-29 18:22:41 as
	SLCO1B1 variants and statin-induced myopathy. [My Copy] The New England journal of medicine, Vol. 360, No. 3. (15 January 2009) by Georgirene D. Vladutiu, Paul J. Isackson posted to statin slco1b1 comments adr by misonneh on 2009-09-29 18:19:21 as
	Pharmacogenomics and drug toxicity. [My Copy] The New England journal of medicine, Vol. 359, No. 8. (21 August 2008), pp. 856-858. by Yusuke Nakamura posted to pharmacogenetics comments adr by misonneh on 2009-09-29 18:18:37 as along with 1 person Amazoness
	SLCO1B1 variants and statin-induced myopathy--a genomewide study. [My Copy] The New England journal of medicine, Vol. 359, No. 8. (21 August 2008), pp. 789-799. by SEARCH Collaborative Group, E. Link, S. Parish, et al.J. Armitage, L. Bowman, S. Heath, F. Matsuda, I. Gut, M. Lathrop, R. Collins posted to statin slco1b1 pharmacogenetics gwas adr by misonneh on 2009-09-29 18:18:08 as along with 1 person michellerouge
	Pharmacogenomics: challenges and opportunities. [My Copy] Annals of internal medicine, Vol. 145, No. 10. (21 November 2006), pp. 749-757. by Dan M. Roden, Russ B. Altman, Neal L. Benowitz, et al.David A. Flockhart, Kathleen M. Giacomini, Julie A. Johnson, Ronald M. Krauss, Howard L. McLeod, Mark J. Ratain, Mary V. Relling, Huijun Z. Ring, Alan R. Shuldiner, Richard M. Weinshilboum, Scott T. Weiss, Pharmacogenetics Research Network posted to review pharmacogenetics perspective adr by misonneh on 2009-09-29 18:13:22 as along with 1 person guhjy
	Pharmacogenomic biomarkers for prediction of severe adverse drug reactions. [My Copy] The New England journal of medicine, Vol. 358, No. 6. (7 February 2008), pp. 637-639. by Magnus Ingelman-Sundberg posted to pharmacogenetics comments adr by misonneh on 2009-09-29 17:46:44 as
	HLA-B5701 screening for hypersensitivity to abacavir. [My Copy] The New England journal of medicine*, Vol. 358, No. 6. (7 February 2008), pp. 568-579. by Simon Mallal, Elizabeth Phillips, Giampiero Carosi, et al.Jean-Michel M. Molina, Cassy Workman, Janez Tomazic, Eva Jägel-Guedes, Sorin Rugina, Oleg Kozyrev, Juan Flores F. Cid, Phillip Hay, David Nolan, Sara Hughes, Arlene Hughes, Susanna Ryan, Nicholas Fitch, Daren Thorborn, Alastair Benbow, PREDICT-1 Study Team posted to immunity adr abacavir by misonneh on 2009-09-29 17:44:25 as
	Epilepsy pharmacogenetics. [My Copy] Pharmacogenomics, Vol. 10, No. 5. (May 2009), pp. 817-836. by Dalia Kasperaviciūte, Sanjay M. Sisodiya posted to review response resistance pharmacogenetics epilepsy adr by misonneh on 2009-09-03 07:14:45 as
	Assessing cancer risks of low-dose radiation [My Copy] Nat Rev Cancer, Vol. 9, No. 8. (August 2009), pp. 596-604. by Leon Mullenders, Mike Atkinson, Herwig Paretzke, Laure Sabatier, Simon Bouffler posted to adr epidemiology genetics perspective radiotherapy review risk_factor by misonneh on 2009-07-27 09:01:44 as along with 1 person leliavski
	Single Nucleotide Polymorphism at rs1982073:T869C of the TGFbeta1 Gene Is Associated With the Risk of Radiation Pneumonitis in Patients With Non-Small-Cell Lung Cancer Treated With Definitive Radiotherapy [My Copy] J Clin Oncol, Vol. 27, No. 20. (10 July 2009), pp. 3370-3378. by Xianglin Yuan, Zhongxing Liao, Zhensheng Liu, et al.Li-E Wang, Susan L. Tucker, Li Mao, Xin S. Wang, Mary Martel, Ritsuko Komaki, James D. Cox, Luka Milas, Qingyi Wei posted to adr genetics lung pharmacogenetics radiotherapy tgf by misonneh on 2009-07-13 10:13:37 as
	Hepatic complications of breast cancer [My Copy] The Lancet Oncology, Vol. 10 (June 2009), pp. 615-651. by Jennifer R. Diamond, Christina A. Finlayson, Virginia F. Borges posted to adr breast review tamoxifen by misonneh on 2009-06-02 06:25:22 as
	Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics [My Copy] J Clin Oncol, Vol. 27, No. 16. (1 June 2009), pp. 2604-2614. by Federico Innocenti, Deanna L. Kroetz, Erin Schuetz, et al.Eileen M. Dolan, Jacqueline Ramirez, Mary Relling, Peixian Chen, Soma Das, Gary L. Rosner, Mark J. Ratain posted to adr irinotecan pathway pharmacogenetics pk by misonneh on 2009-05-29 06:52:24 as
	Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions. [My Copy] The AAPS journal, Vol. 8, No. 1. (2006) by B. O. Gerber, W. J. Pichler posted to adr immunity mhc review by misonneh on 2009-03-25 08:59:45 as
	Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors. [My Copy] Cancer research, Vol. 68, No. 23. (1 December 2008), pp. 9601-9607. by A. F. Setiadi, K. Omilusik, M. D. David, et al.R. P. Seipp, J. Hartikainen, R. Gopaul, K. B. Choi, W. A. Jefferies posted to adr epigenetics immunity mhc by misonneh on 2009-03-25 08:52:14 as
	Pharmacogenetics and adverse drug reactions [My Copy] The Lancet, Vol. 356, No. 9242. (11 November 2000), pp. 1667-1671. by Urs A. Meyer posted to adr pharmacogenetics review by misonneh on 2009-02-16 03:50:26 as along with 1 person reyez
	The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer [My Copy] Breast Cancer Research and Treatment by Cynthia Osborne, Anita Duncan, Scot Sedlacek, et al.Devchand Paul, Frankie Holmes, Svetislava Vukelja, Michael Kasper, Sharon Wilks, Andrew Schneider, Richard Mcgee, Wally Meyer, Joyce O’shaughnessy posted to adr breast tamoxifen by misonneh on 2009-01-23 08:56:48 as
	Gene Testing to Predict Tamoxifen-Induced Hot Flashes: New Biological Insights [My Copy] J Clin Oncol, Vol. 26, No. 36. (20 December 2008), pp. 5841-5842. by Carolyn J. Crandall posted to adr comments genetics tamoxifen by misonneh on 2008-12-22 03:50:03 as
	Severe cutaneous adverse reactions to drugs. [My Copy] Current Opinion in Allergy and Clinical Immunology, Vol. 7, No. 4. (August 2007), pp. 304-309. by F. L. Chia, K. P. Leong posted to adr pharmacogenetics review by misonneh on 2008-11-07 06:29:36 as
	Human leukocyte antigens and drug hypersensitivity. [My Copy] Current Opinion in Allergy and Clinical Immunology, Vol. 7, No. 4. (August 2007), pp. 317-323. by W. H. Chung, S. I. Hung, Y. T. Chen posted to adr hla pharmacogenetics review by misonneh on 2008-11-07 06:28:34 as
	Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. [My Copy] Pharmacogenetics and Genomics, Vol. 16, No. 4. (April 2006), pp. 297-306. by S. I. Hung, W. H. Chung, S. H. Jee, et al.W. C. Chen, Y. T. Chang, W. R. Lee, S. L. Hu, M. T. Wu, G. S. Chen, T. W. Wong, P. F. Hsiao, W. H. Chen, H. Y. Shih, W. H. Fang, C. Y. Wei, Y. H. Lou, Y. L. Huang, J. J. Lin, Y. T. Chen posted to adr carbamazepine hla pharmacogenetics race review by misonneh on 2008-11-06 06:18:43 as
	HLA-B locus in Caucasian patients with carbamazepine hypersensitivity [My Copy] Pharmacogenomics, Vol. 7, No. 6. (September 2006), pp. 813-818. by Alfirevic, Ana, Jorgensen, et al.L. Andrea, Williamson, R. Paula, Chadwick, W. David, Park, B. Kevin, Pirmohamed, Munir posted to adr carbamazepine hla pharmacogenetics race by misonneh on 2008-11-06 06:18:05 as
	Strong association between HLA-A0206 and Stevens-Johnson syndrome in the Japanese. [My Copy] American journal of ophthalmology*, Vol. 143, No. 2. (February 2007), pp. 367-368. by M. Ueta, C. Sotozono, K. Tokunaga, T. Yabe, S. Kinoshita posted to adr carbamazepine hla pharmacogenetics race by misonneh on 2008-11-06 06:17:23 as
	A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. [My Copy] Pharmacogenetics and Genomics, Vol. 18, No. 2. (February 2008), pp. 99-107. by C. Lonjou, N. Borot, P. Sekula, et al.N. Ledger, L. Thomas, S. Halevy, L. Naldi, J. N. Bouwes-Bavinck, A. Sidoroff, C. de Toma, M. Schumacher, J. C. Roujeau, A. Hovnanian, M. Mockenhaupt posted to adr carbamazepine hla pharmacogenetics by misonneh on 2008-11-06 06:16:00 as
	HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese. [My Copy] Molecular vision, Vol. 14 (2008), pp. 550-555. by M. Ueta, K. Tokunaga, C. Sotozono, et al.T. Inatomi, T. Yabe, M. Matsushita, Y. Mitsuishi, S. Kinoshita posted to adr carbamazepine hla pharmacogenetics race by misonneh on 2008-11-06 06:15:23 as
	Carbamazepine, HLA-B1502 and risk of StevensJohnson syndrome and toxic epidermal necrolysis: US FDA recommendations [My Copy] Pharmacogenomics*, Vol. 9, No. 10. (October 2008), pp. 1543-1546. by Ferrell, P. Brent, Mcleod, L. Howard posted to adr carbamazepine hla pharmacogenetics race review by misonneh on 2008-11-06 06:14:18 as

Note: You may cite this page as: http://www.citeulike.org/user/misonneh/tag/adr

review	314
breast	263
genetics	170
epigenetics	161
methylation	153
pharmacogenetics	144
statistics	90
gene_specific_methylation	66
comments	65
biomarker	65
gwas	64
prognosis	61
meta_analysis	55
association	54
tamoxifen	53
chemotherapy	50
moa	47
peripheral	47
gxe	46
diet	43
folate	40
response	38
modeling	38
survival	36
resistance	36
guideline	35
prediction	33
global	33
epidemiology	31
epistasis	30
adr	30
korean	28
dynamic	28
time_to_event	28
prostate	28
technology	27
haplotype	26
diagnosis	26
cyp2d6	25
race	23
expression	23
neoadjuvant	22
instability	21
colon	21
circ_dna	21
database	20
prevention	20
environment	20
progression	19
risk_factor	17
lung	17
pooling	17
perspective	17
therapy	16
line1	16
immunity	15
phenotype	15
target_dna	14
invivo	13
clinic	13
hr	13
1-carbon	13
tool	13
kfdap_112909	13
randomized_controlled_trial	13
age	12
5mdc	12
tutorial	12
gxg	11
data_mining	11
mirna	11
pk	11
hematology	11
metastasis	11
bladder	10
estrogen	10
pathway	9
mdr1	9
exposure	9
hormone	9
smoking	9
her2	9
cancer	8
gst	8
design	8
fda	8
heterogeneity	8
lifestyle	8
epilepsy	8
esr1	8
reproductive	8
bias	8
ivive	8
trend	7
subtypes	7
kim_	7
dnmt	7
cyp450	7
prenatal	7
metabolism	7
cnv	7
mthfr	7
power	7
etiology	7
hla	7
histone	6
system_biology	6
summary	6
drug_discovery	6
dna_repair	6
ddi	6
cell	6
hyper_hypo	6
maternal	6
methodology	6
cohort	6
carbamazepine	6
alcohol	6
pcb	6
mortality	5
intervention	5
array	5
cervix	5
nos3	5
mhc	5
mgmt	5
microarray	5
benign	5
translation	5
chemoprevention	5
fundamental_concept_s1	5
pet	5
inheritance	5
disparities	4
detection	4
refractory	4
basal-like	4
bmd	4
bayesian	4
triple-negative	4
tsnp	4
cimp	4
cns	4
pathology	4
asian_populations	4
observation	4
transport	4
biobank	4
leukemia	4
balanced	4
linkage	4
ntissue	4
toxicity	3
swog	3
ros	3
fu	3
egfr_pathway	3
intrauterine	3
ovarian	3
cytokine	3
risk_assessment	3
statin	3
sult1a1	3
glioblastoma	3
antioxidant	3
cyp1a1	3
validation	3
cluster	3
molecular	3
sult1e1	3
aml	3
demethylation	3
public	3
metformin	3
mds	3
hitchhiking	3
diabetes	2
immortalization	2
comt	2
radiotherapy	2
oral	2
cyp2c19	2
kawasaki	2
allergy	2
wnt	2
epigenetic_therapy	2
quantitative_traits	2
anthracycline	2
brain	2
insilico	2
pharmacodynamic	2
cyp2e1	2
apoptosis	2
finasteride	2
consorcium	2
ovary	2
lymphoma	2
fprp	2
grail	2
childhood	2
benzopyrene	2
brca	2
definition	2
classification	2
endometrix	2
atm	2
nqo1	2
aspirin	2
toxicology	2
bisphenol	2
decitabine	2
caret	2
iron	2
phase	2
isoflavone	2
feature_selection	2
testicular	2
slco1b1	2
s8897	2
key	2
genotype	2
specimen	2
hematopoiety	2
ki67	2
irinotecan	2
polycomb	2
aromatase_inhibitor	2
mnsod	2
brca12	2
ugt	2
parent_study	2
nutrition	2
protocol	2
tpmt	2
cdk	1
pharmacogenomics	1
prevalence	1
p53	1
tea	1
cisplatin	1
hnscc	1
5-alpha_reductase	1
meta_anlaysis	1
fun	1
practice	1
bmp	1
neurod1	1
glioma	1
networking	1
src	1
sputum	1
plink	1
polymapr	1
cat	1
stromal_component	1
alkylating_agents	1
tp53	1
oncotypedx	1
parity	1
mpo	1
cyclophosphamide	1
scn	1
antidepressant	1
lipidadjust	1
phytoestrogen	1
opg	1
osteoporosis	1
nsaid	1
mrp3	1
cyp1b1	1
nrf2	1
peakbmd	1
dcic	1
tgf	1
obesity	1
catechol	1
azacitidine	1
steroid	1
rcc	1
psychoses	1
cyp2c9	1
silencing_rna	1
population	1
resonse	1
ugt1a1	1
liver	1
xrcc1	1
ho1	1
cell_cycle_control	1
histology	1
read_	1
aldh2	1
benzene	1
decision	1
cml	1
endpoint	1
pax2	1
epidgenetics	1
illumina	1
temozolomide	1
myc	1
fastsnp	1
compliance	1
warfarin	1
pharmacokinetic_variability	1
example	1
diganosis	1
no	1
invitro	1
qsar	1
multitest	1
cyp19	1
casp8	1
integration	1
heritability	1
hif1a	1
tgm2	1
outcome	1
immunoprecipitation	1
lactation	1
multiple_myeloma	1
aldh1	1
journal_club	1
twin_study	1
xrcc3	1
paternal	1
interleukin	1
rank	1
acs	1
gpx1	1
cyp1a2	1
dag	1
series	1
history	1
s100p	1
fmr1	1
nhs	1
sfrp5	1
cyp3a4	1
oralscc	1
maspin	1
gstp1	1
inflammtion	1
assay	1
mining	1
cbr3	1
rfc	1
meternal	1
polyphenol	1
confounder	1
nuclear_receptor	1
infection	1
abacavir	1
digoxin	1
index	1
ecadherin	1
xpd	1
mapping	1
family_hx	1
proression	1
splicing	1
hpv	1
peripheral_blood	1
sat2	1
mbd2	1
methotrexate	1
consortium	1
hogg1	1
alternative	1
metabolomics	1

misonneh's adr [30 articles] Export

misonneh's tags